Recursion Pharmaceuticals (RXRX) Earnings Date & Reports
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
RXRX is expected to report earnings to fall 13.52% to -21 cents per share on November 11
Q3'26
Est.
$-0.22
Q2'26
Missed
by $0.01
Q1'26
Beat
by $0.04
Q4'25
Beat
by $0.09
Q3'25
Beat
by $0.01
The last earnings report on August 05 showed earnings per share of -25 cents, missing the estimate of -23 cents. With 6.49M shares outstanding, the current market capitalization sits at 2.11B.